Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • NPPA fixes prices of...

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-04-12T13:37:44+05:30  |  Updated On 12 April 2020 1:37 PM IST
    NPPA fixes prices of 29 formulations under DPCO, check out details

    Many of the drugs whose price has been fixed includes popular cardio-diabetes products, paracetemol combinations, and many more

    New Delhi: Through a recent order the apex drug price controller, National Pharmaceutical Pricing Authority (NPPA) has fixed the price of 29 drug formulations. Many of the drugs whose price has been fixed includes popular cardio-diabetes products, paracetemol combinations, and many more

    In the recent order issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of goods and services tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof:


    Sl.

    No.

    Name of the Formulation

    / Brand Name

    Strength

    Unit

    Manufacturer &

    Marketing Company

    Retail Price (Rs.)

    (1)

    (2)

    (3)

    (4)

    (5)

    (6)

    1.

    Metoprolol Tablet

    Each film-coated extended-release tablet contains:

    Metoprolol Succinate IP 95mg eq.

    to Metoprolol Tartrate 100mg

    1 Tablet

    M/s Cipla Ltd.

    10.34

    2.

    Vildagliptin + Metformin

    Tablet (Vildaprime-M

    50/500)

    Each film-coated tablet contains:

    Vildagliptin 50mg,

    Metformin Hydrochloride IP 500mg,

    1 Tablet

    M/s Swiss Garnier Genexia

    Sciences Pvt. Ltd. / M/s

    Primus Remedies Pvt. Ltd.

    6.17

    3.

    Vildagliptin + Metformin

    Tablet (Vildaprime-M

    50/850)

    Each film-coated tablet contains:

    Vildagliptin 50mg,

    Metformin Hydrochloride IP 850mg

    1 Tablet

    M/s Swiss Garnier Genexia

    Sciences Pvt. Ltd. / M/s

    Primus Remedies Pvt. Ltd.

    6.24

    4.

    Vildagliptin + Metformin

    Tablet (Vildaprime-M

    50/1000)

    Each film-coated tablet contains:

    Vildagliptin 50mg,

    Metformin Hydrochloride IP

    1000mg,

    1 Tablet

    M/s Swiss Garnier Genexia

    Sciences Pvt. Ltd. / M/s

    Primus Remedies Pvt. Ltd.

    6.81

    5.

    Trypsin & Chymotripsin + Paracetamol + Aceclofenac Tablet (Zerodol TC

    Each film-coated tablet contains: 50,000 Armour Units Enzymatic Activity Supplied by purified concentrate which has specific Trypsin & Chymotripsin activity in a ratio of approximately six to One (as enteric-coated granuales) Paracetamol IP 325mg, Aceclofenac IP 100mg

    1 Tablet

    M/s Synokem

    Pharmaceuticals Ltd. / M/s

    Ipca Laboratories Ltd.

    8.29

    6.

    Emtricitabine + Tenofovir Alafenamide Tablet (TAFNAT-EM)

    Each film coated Tablet contains:

    Emtricitabine IP 200mg,

    Tenofovir Alafenamide Fumarate

    eq. to Tenofovir Alafenamide 25mg

    1 Tablet

    M/s Natco Pharma Limited

    51.34

    7.

    Chlorpheniramine +

    Phenylephrine Syrup

    Each ml syrup contains: Chlorpheniramine Maleate IP 2mg, Phenylephrine Hydrocloride IP 5mg

    Per ml

    M/s Windlas Biotech Pvt.

    Ltd. / M/s Zydus Healthcare

    Limited

    0.90

    8.

    Chlorpheniramine +

    Phenylephrine Drops

    Each ml drops contains:

    Chlorpheniramine Maleate Ip 1mg,

    Phenylephrine Hydrocloride IP

    2.5mg

    Per ml

    M/s Windlas Biotech Pvt.

    Ltd. / M/s Zydus Healthcare

    Limited

    3.13

    9.

    Paracetamol +

    Chlorpheniramine +

    Phenylephrine Tablet

    Each uncoated tablet contains:

    Paracetamol IP 500mg,

    Chlorpheniramine Maleate IP 2mg,

    Phenylephrine Hydrocloride IP

    10mg

    1 Tablet

    M/s Windlas Biotech Pvt.

    Ltd. / M/s Zydus Healthcare

    Limited

    3.29

    10.

    Atorvastatin + Clopidogrel

    + Aspirin Capsule

    Each hard gelatine capsule contains:

    Atorvastatin Calcium IP eq. to

    Atorvastatin 10mg,

    Clopidogrel Bisulphate IP eq. to

    Clopidogrel 75mg,

    Aspirin IP 75mg (As enteric coated

    pellets)

    1 Capsule

    M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd

    3.90

    11.

    Atorvastatin + Clopidogrel

    + Aspirin Capsule

    Each hard gelatine capsule

    contains:Atorvastatin Calcium IP

    eq. to Atorvastatin

    20mg,Clopidogrel Bisulphate IP eq.

    to Clopidogrel 75mg,Aspirin IP

    75mg (As enteric coated pellets)

    1 Capsule

    M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Abbott Healthcare Pvt. Ltd.

    5.27

    12.

    Telmisartan + Cilnidipine

    + Metoprolol Tablet

    Each film-coated Bilayered Tablet contains: Telmisartan IP 40mg Cilnidipine IP 10mg, Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate 25mg (As Extended-Release)

    1 Tablet

    M/s Micro Labs Limited

    9.64

    13.

    Telmisartan + Cilnidipine

    + Metoprolol Tablet

    Each film-coated Bilayered Tablet

    contains:

    Telmisartan IP 40mg

    Cilnidipine IP 10mg,

    Metoprolol Succinate IP 47.50mg

    eq. to Metoprolol Tartrate 50mg (As

    Extended-Release)

    1 Tablet

    M/s Micro Labs Limited

    11.96

    14.

    Tranexamic Tablet

    Each Film-coated tablet contains: Tranexamic Acid IP 250mg

    1 Tablet

    M/s Pharma Synth Formulations Ltd/ M/s La Prisine Bioceuticals Pvt. Ltd

    15.30

    15.

    Esomeprazole +

    Domperidone Capsule

    Each hard gelatin capsule contains:

    Esomeprazole Magnesium Trihdrate

    IP eq. to Esomeprazole 40mg (as

    enteric coated pellets)

    Domperidone IP 30mg (as sustained

    release pellets)

    1 Capsule

    M/s East African (India)

    Overseas / M/s Zydus

    Healthcare Limited

    8.94

    16.

    Teneligliptin + Metformin

    Tablet

    Each uncoated bilayered tablet

    contains:

    Teneligliptin Hydrobromide

    Hydrate eq. to Teneligliptin 20mg

    Metformin HCl 500mg (SR)

    1 Table

    M/s Synokem

    Pharmaceuticals Ltd. / M/s

    Apex Laboratories Private

    Limited

    10.45

    17.

    Sucralfate + Oxetacaine

    Suspension

    Each 5ml suspension contains:

    Sucralfate IP 1gm,

    Oxetacaine BP 10mg

    Per ml

    M/s Pure & Cure Healthcare

    Pvt. Ltd. / Dr. Reddy's

    Laboratories Ltd.

    0.95

    18.

    Folic Acid + Methylcobalamin Tablet (FDSON-12 SL)

    Each uncoated tablet contains:

    Folic Acid IP 5mg,

    Methylcobalamin IP 750mcg

    1 Tablet

    M/s Unison Pharmaceuticals Pvt. Ltd.

    2.34

    19.

    Calcium Carbonate +

    Cholecalciferol Tablet

    (Macalvit Forte)

    Each film-coated tablet contains:

    Calcium Carbonate IP 1.250g, eq. to

    Elemental Calcium 500mg,

    Cholecalciferol (Stabilized) eq. to

    Cholecalciferol IP 500IU (Vitamin

    D3)

    1 Tablet

    M/s Akums Drugs &

    Pharmaceuticals Ltd. / M/s

    Novartis India Limited

    10.00

    20.

    Esomeprazole +

    Domperidone Capsule

    Each hard gelatin capsule contains: Esomeprazole Magnesium Trihdrate IP eq. to Esomeprazole 40mg (as enteric coated pellets) Domperidone IP 30mg (as sustained release pellets)

    1 Capsule

    M/s Nest Healthcare Pvt.

    Ltd. / M/s Cadila

    Pharmaceuticals Limited

    8.94

    21.

    Temisartan + Metoprolol

    Tablet

    Each film-coated bilayered Tablet

    contains:

    Temisartan IP 40mg, Metoprolol Succinate IP 23.75mg

    eq. to Metoprolol Tartrate IP 25mg

    (As extended Release)

    1 Tablet

    M/s Sun Pharma

    Laboratories Limited

    10.58

    22.

    Temisartan + Metoprolol

    Tablet

    Each film-coated bilayered Tablet contains: Temisartan IP 40mg, Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate IP 50mg (As extended Release)

    1 Tablet

    M/s Sun Pharma Laboratories Limited

    12.69

    23.

    Telmisartan +

    Chlorthalidone Tablet

    (Tamica-CT 40/6.25)

    Each un-coated Bi-Layered tablet

    contains:

    Telmisartan IP 40mg,

    Chlorthalidone IP 6.25mg

    1 Tablet

    M/s Theon Pharmaceuticals Ltd. / M/s Alkem Laboratories Ltd

    7.82

    24.

    Domperidone + Naproxen

    Sodium Tablet

    Each film coated tablet contains:

    Domperidone Maleate IP eq. to

    Domperidone 10mg,

    Naproxen Sodium USP 275mg eq.

    to Naproxen 250mg

    1 Tablet

    M/s Akums Drugs &

    Pharmaceuticals Ltd. / M/s

    Torrent Pharmaceuticals

    Pvt. Ltd.

    4.78

    25.

    Domperidone + Naproxen

    Sodium Tablet

    Each film coated tablet contains:

    Domperidone Maleate IP eq. to

    Domperidone 10mg,

    Naproxen Sodium USP 550mg eq.

    to Naproxen 500mg

    1 Tablet

    M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Torrent Pharmaceuticals Pvt. Ltd.

    5.93

    26.

    Gliclazide + Metformin

    Hydrochloride Tablet

    Each uncoated tablet contains: Gliclazide IP 80mg, Metformin Hydrochloride IP 500mg

    1 Tablet

    M/s Innova Captab Limited / M/s Abbott Healthcare Pvt. Ltd

    6.86

    27.

    Thiocolchicoside + Aceclofenac + Paracetamol Tablet (Zerodol TH 4 Max)

    Each Film Coated Tablet contains: Thiocolchicoside IP 4mg, Aceclofenac IP 100mg, Paracetamol IP 325mg

    1 Tablet

    M/s Akums Drugs &

    Pharmaceuticals Ltd. / M/s

    Ipca Laboratories Ltd.

    14.04

    28.

    Thiocolchicoside +

    Aceclofenac + Paracetamol

    Tablet (Zerodol TH 8 Max)

    Each Film Coated Tablet contains:

    Thiocolchicoside IP 8mg,

    Aceclofenac IP 100mg,

    Paracetamol IP 325mg

    1 Tablet

    M/s Akums Drugs &

    Pharmaceuticals Ltd. / M/s

    Ipca Laboratories Ltd.

    21.40

    29.

    Linezolid + Dextrose

    Water for Injection (GALLINI I.V.)

    Each 100ml contains: Linezolid IP 200mg Dextrose Anhydrous IP 5g Water for Injection

    Per 300 ml

    pack

    M/s Aishwarya Lifesciences

    / M/s Galpha Laboratories

    Limited

    342.08

    Note:

    (a) The manufacturer of the above-mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

    (b) The manufacturer may add goods and services tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above-said table.

    (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

    (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

    (e) The above mentioned retail price is applicable only to the individual manufacturer/marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation/revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

    (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.

    (g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

    To read the full article click on the following link:

    https://business.medicaldialogues.in/pdf_upload/pdf_upload-126340.pdf


    nppadpconational-pharmaceutical-pricing-authority

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok